Hispanic patients with IBD at increased risk for hospitalization, surgery
Hispanic patients treated with biologic agents for inflammatory bowel diseases face a greater risk for hospitalization, surgery and infections compared with non-Hispanic patients, according to a study in Clinical Gastroenterology and Hepatology.“Hispanic patients have been underrepresented in clinical trials of biologic agents in IBD, and hence, there is limited data on effectiveness and safety of these agents in Hispanics,” Nghia H. Nguyen, MD, a GI fellow in medicine at UC San Diego Health, and colleagues wrote. “In our real-world study of new users of biologic agents, weRead More
